Back to search
Phosphorus and Calcium Disorders
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Phosphorus and Calcium Disorders trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Phosphorus and Calcium Disorders trials you may qualify forA first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
X-linked hypophosphataemia (XLH) is a rare, hereditary condition. The genetic defect leads to low blood phosphate levels and vitamin D suppression. Phosphate is…
The goal of this clinical trial is to learn if calcium-phosphorus regulation therapy can slow the progression of heart valve calcification in patients with dege…
This is an international, multicentre, prospective, non-interventional, observational Registry of patients with X-Linked hypophosphatemia (XLH). The main object…
Children and adults with XLH recruited will be treated with calcitriol alone (without phosphate supplementation) for one year, during which the calcitriol dose…
The objectives of this observational study are to characterize XLH disease presentation and progression and to assess long-term effectiveness and safety of buro…
Through observation of patients with X-linked hypophosphatemic rickets/osteomalacia (XLH) for up to 10 years, the study intends to collect data that allow achie…